The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity (Q40025080)

16 September 2017

The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity (English)

1 reference

16 September 2017

5

Stig Linder

1 reference

16 September 2017

4

Masakazu Toi

1 reference

16 September 2017

Takayuki Ueno

1

1 reference

16 September 2017

Göran Elmberger

series ordinal

2

1 reference

16 September 2017

Timothy E Weaver

series ordinal

3

1 reference

16 September 2017

14 January 2008

1 reference

16 September 2017

Laboratory Investigation

1 reference

16 September 2017

88

1 reference

16 September 2017

256-263

1 reference

16 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700718

16 September 2017

0 references

cites work

Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

An alternatively spliced variant of cathepsin E in human gastric adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Molecular cloning of a novel mouse aspartic protease-like protein that is expressed abundantly in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Napsins: new human aspartic proteinases. Distinction between two closely related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Human napsin A: expression, immunochemical detection, and tissue localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Processing of pulmonary surfactant protein B by napsin and cathepsin H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Cellular distribution of napsin (kidney-derived aspartic protease-like protein, KAP) mRNA in the kidney, lung and lymphatic organs of adult and developing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Structural requirements for intracellular transport of pulmonary surfactant protein B (SP-B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Deletion mapping of N-terminal domains of surfactant protein A. The N-terminal segment is required for phospholipid aggregation and specific inhibition of surfactant secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Purification and characterization of active recombinant human napsin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Evolution in the structure and function of aspartic proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Clinical significance of cathepsin D in primary ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Single-step purification/solubilization of recombinant proteins: application to surfactant protein B

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Biological and clinical significance of cathepsin D in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

Procathepsin D cannot autoactivate to cathepsin D at acid pH

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700718

7 January 2021

10.1038/LABINVEST.3700718

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference